The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties
The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the...
Gespeichert in:
Veröffentlicht in: | Journal of immunological methods 1996-08, Vol.194 (2), p.191-199 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 199 |
---|---|
container_issue | 2 |
container_start_page | 191 |
container_title | Journal of immunological methods |
container_volume | 194 |
creator | Schlaeger, Ernst-Jürgen |
description | The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood. |
doi_str_mv | 10.1016/0022-1759(96)00080-4 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78266945</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0022175996000804</els_id><sourcerecordid>78266945</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</originalsourceid><addsrcrecordid>eNqFkd2KFDEQhRtR1nH1DRRyIaKwrUlPd35uBFn8gwFF1utQk1TvRLqTNkmvzMP5bqadZi71KiT11TmVOlX1lNHXjDL-htKmqZno1EvFX1FKJa3be9WGSdHUQtHufrU5Iw-rRyn9KBCjnF5UF1LwjolmU_2-OSCZYsjoPDkcbQzDMUHGK_I1uhFy8Ei-7a6ISwSICSnX2PdosrtDMs5DdtOA5DaGX_mwyIxFKJLQkxHGEQYHnhgcBmIKOkckxSRhnMfaBJ_BeedvCXi7PvYRiypaB38frUvTAMfi7LOrYQpTDqkMUnwmjNlhelw96GFI-GQ9L6vvH97fXH-qd18-fr5-t6tNy0SuwfYgTN8gMLUHtlWNNKA4sD0X2ANYurfMtmbLlepkJ9E2zApjOMWtssJuL6sXJ91i_XPGlPXo0vIx8BjmpIVsOFdt91-QdZIr2cgCtifQxJBSxF5Py77jUTOql3j1kp1estNquZR4dVvanq36874s6ty05lnqz9c6JANDH8Ebl87Ylkkl5CLz9oRhWdqdw6iTcehNWX0s4Wob3L_n-APnNsav</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15869828</pqid></control><display><type>article</type><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Schlaeger, Ernst-Jürgen</creator><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><description>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</description><identifier>ISSN: 0022-1759</identifier><identifier>EISSN: 1872-7905</identifier><identifier>DOI: 10.1016/0022-1759(96)00080-4</identifier><identifier>PMID: 8765172</identifier><identifier>CODEN: JIMMBG</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animal cells ; Animals ; Apoptosis ; Apoptosis - drug effects ; Biological and medical sciences ; Cell culture ; Cell cultures. Hybridization. Fusion ; Cell Division - drug effects ; Cells, Cultured ; Cost-Benefit Analysis ; Culture Media ; Culture Media, Serum-Free ; Cytological Techniques ; Fundamental and applied biological sciences. Psychology ; Growth Substances - economics ; Growth Substances - pharmacology ; HL-60 Cells - cytology ; HL-60 Cells - drug effects ; Humans ; Hybridoma ; Hybridomas - cytology ; Hybridomas - drug effects ; Mice ; Molecular and cellular biology ; Monoclonal antibody ; Multiple Myeloma - pathology ; Primatone RL ; Protein Hydrolysates - economics ; Protein Hydrolysates - pharmacology ; Serum-free ; Tumor Cells, Cultured - drug effects</subject><ispartof>Journal of immunological methods, 1996-08, Vol.194 (2), p.191-199</ispartof><rights>1996</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</citedby><cites>FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0022175996000804$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3189784$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8765172$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><title>Journal of immunological methods</title><addtitle>J Immunol Methods</addtitle><description>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</description><subject>Animal cells</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cell culture</subject><subject>Cell cultures. Hybridization. Fusion</subject><subject>Cell Division - drug effects</subject><subject>Cells, Cultured</subject><subject>Cost-Benefit Analysis</subject><subject>Culture Media</subject><subject>Culture Media, Serum-Free</subject><subject>Cytological Techniques</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Growth Substances - economics</subject><subject>Growth Substances - pharmacology</subject><subject>HL-60 Cells - cytology</subject><subject>HL-60 Cells - drug effects</subject><subject>Humans</subject><subject>Hybridoma</subject><subject>Hybridomas - cytology</subject><subject>Hybridomas - drug effects</subject><subject>Mice</subject><subject>Molecular and cellular biology</subject><subject>Monoclonal antibody</subject><subject>Multiple Myeloma - pathology</subject><subject>Primatone RL</subject><subject>Protein Hydrolysates - economics</subject><subject>Protein Hydrolysates - pharmacology</subject><subject>Serum-free</subject><subject>Tumor Cells, Cultured - drug effects</subject><issn>0022-1759</issn><issn>1872-7905</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkd2KFDEQhRtR1nH1DRRyIaKwrUlPd35uBFn8gwFF1utQk1TvRLqTNkmvzMP5bqadZi71KiT11TmVOlX1lNHXjDL-htKmqZno1EvFX1FKJa3be9WGSdHUQtHufrU5Iw-rRyn9KBCjnF5UF1LwjolmU_2-OSCZYsjoPDkcbQzDMUHGK_I1uhFy8Ei-7a6ISwSICSnX2PdosrtDMs5DdtOA5DaGX_mwyIxFKJLQkxHGEQYHnhgcBmIKOkckxSRhnMfaBJ_BeedvCXi7PvYRiypaB38frUvTAMfi7LOrYQpTDqkMUnwmjNlhelw96GFI-GQ9L6vvH97fXH-qd18-fr5-t6tNy0SuwfYgTN8gMLUHtlWNNKA4sD0X2ANYurfMtmbLlepkJ9E2zApjOMWtssJuL6sXJ91i_XPGlPXo0vIx8BjmpIVsOFdt91-QdZIr2cgCtifQxJBSxF5Py77jUTOql3j1kp1estNquZR4dVvanq36874s6ty05lnqz9c6JANDH8Ebl87Ylkkl5CLz9oRhWdqdw6iTcehNWX0s4Wob3L_n-APnNsav</recordid><startdate>19960814</startdate><enddate>19960814</enddate><creator>Schlaeger, Ernst-Jürgen</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>19960814</creationdate><title>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</title><author>Schlaeger, Ernst-Jürgen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-adfa7cf2ea19ba13928ca96a1b67efaad0bd1d4c36995858ed21d7cc60e39d7d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Animal cells</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cell culture</topic><topic>Cell cultures. Hybridization. Fusion</topic><topic>Cell Division - drug effects</topic><topic>Cells, Cultured</topic><topic>Cost-Benefit Analysis</topic><topic>Culture Media</topic><topic>Culture Media, Serum-Free</topic><topic>Cytological Techniques</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Growth Substances - economics</topic><topic>Growth Substances - pharmacology</topic><topic>HL-60 Cells - cytology</topic><topic>HL-60 Cells - drug effects</topic><topic>Humans</topic><topic>Hybridoma</topic><topic>Hybridomas - cytology</topic><topic>Hybridomas - drug effects</topic><topic>Mice</topic><topic>Molecular and cellular biology</topic><topic>Monoclonal antibody</topic><topic>Multiple Myeloma - pathology</topic><topic>Primatone RL</topic><topic>Protein Hydrolysates - economics</topic><topic>Protein Hydrolysates - pharmacology</topic><topic>Serum-free</topic><topic>Tumor Cells, Cultured - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schlaeger, Ernst-Jürgen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of immunological methods</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schlaeger, Ernst-Jürgen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties</atitle><jtitle>Journal of immunological methods</jtitle><addtitle>J Immunol Methods</addtitle><date>1996-08-14</date><risdate>1996</risdate><volume>194</volume><issue>2</issue><spage>191</spage><epage>199</epage><pages>191-199</pages><issn>0022-1759</issn><eissn>1872-7905</eissn><coden>JIMMBG</coden><abstract>The tryptic meat digest Primatone RL is a low-cost medium supplement of a complex nature which serves as a source of amino acids, oligopeptides, iron salts, some lipids and other trace low molecular weight substances. Its addition to mammalian and insect cell culture media significantly improves the cell growth properties of many cell lines. In this work the growth promoting effects of Primatone RL are described in more detail using different mouse hybridomas, a mouse myeloma cell line, and human promyelocytic leukemia HL-60 cells. The positive effects on cell growth induced by Primatone were observed in the presence of serum but were even more pronounced in serum-free culture. In addition the adaptation time from high serum to low (1%) or serum-free growth in the presence of Primatone is also significantly reduced. Primatone RL, when added to HL and DHI medium, improves cell growth under low serum or serum-free conditions by increasing the maximum cell numbers and in particular the viability of the culture. The observed decrease in cell death (apoptosis) induction leads to a significant improvement in antibody (recombinant protein) production by increasing the volumetric yields during long-term batch culture. The so-called anti-apoptotic effects of Primatone RL for mouse hybridomas, which is concentration dependent, is not fully understood.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>8765172</pmid><doi>10.1016/0022-1759(96)00080-4</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1759 |
ispartof | Journal of immunological methods, 1996-08, Vol.194 (2), p.191-199 |
issn | 0022-1759 1872-7905 |
language | eng |
recordid | cdi_proquest_miscellaneous_78266945 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animal cells Animals Apoptosis Apoptosis - drug effects Biological and medical sciences Cell culture Cell cultures. Hybridization. Fusion Cell Division - drug effects Cells, Cultured Cost-Benefit Analysis Culture Media Culture Media, Serum-Free Cytological Techniques Fundamental and applied biological sciences. Psychology Growth Substances - economics Growth Substances - pharmacology HL-60 Cells - cytology HL-60 Cells - drug effects Humans Hybridoma Hybridomas - cytology Hybridomas - drug effects Mice Molecular and cellular biology Monoclonal antibody Multiple Myeloma - pathology Primatone RL Protein Hydrolysates - economics Protein Hydrolysates - pharmacology Serum-free Tumor Cells, Cultured - drug effects |
title | The protein hydrolysate, Primatone RL, is a cost-effective multiple growth promoter of mammalian cell culture in serum-containing and serum-free media and displays anti-apoptosis properties |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T11%3A43%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20protein%20hydrolysate,%20Primatone%20RL,%20is%20a%20cost-effective%20multiple%20growth%20promoter%20of%20mammalian%20cell%20culture%20in%20serum-containing%20and%20serum-free%20media%20and%20displays%20anti-apoptosis%20properties&rft.jtitle=Journal%20of%20immunological%20methods&rft.au=Schlaeger,%20Ernst-J%C3%BCrgen&rft.date=1996-08-14&rft.volume=194&rft.issue=2&rft.spage=191&rft.epage=199&rft.pages=191-199&rft.issn=0022-1759&rft.eissn=1872-7905&rft.coden=JIMMBG&rft_id=info:doi/10.1016/0022-1759(96)00080-4&rft_dat=%3Cproquest_cross%3E78266945%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15869828&rft_id=info:pmid/8765172&rft_els_id=0022175996000804&rfr_iscdi=true |